And finally, during the 1990s, improvement of population quality became an equally important demographic goal for the Communist Party in China (Greenhalgh, 2010). Family planning slogans, commonly seen displayed on billboards throughout the country, were adjusted accordingly to proclaim “Control population growth, raise the quality of the population” or “In raising the quality of the population, family planning is of vital importance.” This time it was medical doctors in charge of genetic counseling and prenatal care who were given the task of “improving the quality of the newborn population” (P. R. China 1994, Article 1) through premarital health checks as well as prenatal screening and testing as means to prevent the birth of children “suffering from a genetic disease of a serious nature” or “a defect of a serious nature” (ibid., Articles 18 and 19; see also Sleeboom-Faulkner, 2010a & b; Zhu 2013; chapter 2). With this law, family planning in China expanded its responsibility beyond limiting the number of children being born to assuring the quality and health of newborns. When ARTs were legalized in 2003, regulations stipulated that fertility clinics “must obey national population and family planning legislation and policies,” which included “promot[ing] population quality” (MoH, 2003a, pp. B1, E1). As a result, sperm banking in China is today an ART and an SRT (selective reproductive technology), by which I mean a technology used not only to assist involuntarily childless couples to conceive, but also to prevent or promote the birth of certain kinds of children (Gammeltoft & Wahlberg, 2014). In the face of a looming national “sperm crisis,” sperm banking has been seen as a way to achieve better population quality through the selective recruitment of “high-quality” (suzhi gao) donors.
At the same time, however, fears about the detrimental impact of consanguineous marriage on population quality have emerged as a hindrance to the business model of Chinese sperm banks. Chinese regulations strictly limit the number of women who can give birth to a child with sperm from a single donor to five. The most common explanation I heard for this “restrictive” limit is that it reduces the risk of unwitting consanguineous marriage (which in turn is seen to increase the risk of birth defects) while also reducing the risk of unwittingly spreading a genetic disease (should a sperm donor turn out to have a late-onset genetic disorder that was not caught through standard screening procedures). China’s five-women’s-pregnancies limit coupled with the sheer demographic and epidemiological scale of male infertility has generated unique and arduous daily routines in Chinese sperm banks, which need to recruit and screen substantially more (potential) donors than Western sperm banks do to serve similar numbers of families.4 At the same time, infertile couples will often have to wait two to three years before being able to access donor sperm because of a chronic “state of emergency” at sperm banks.
And so, to get to grips with how a medical technology like sperm banking came to be an established practice in China over the past three decades or so, we need to understand how this practice has been shaped by (among many other conditions) the crude laboratory conditions available in China throughout the 1980s (and indeed into the 1990s), the co-circulation of deficiency and biomedicalized interpretations of infertility in clinics and among infertile couples, a family planning program designed to prevent rather than promote birth, taboos around sex and masturbation, and anxieties about possible unwitting consanguineous marriages between donor siblings. Only then can we account for the unique form of sperm banking that we find in China today.
SPERM BANKING IN CHINA
In what follows, I will show how sperm banking came to be a routinized part of China’s restrictive reproductive complex. It is the making of sperm banking rather than the experience of donors or couples undergoing AID that is the object of my ethnography. As such, Good Quality is what I would call an assemblage ethnography, combining not so much multisited (Marcus, 1995) as a site-multiplied tracking strategy with a cartographic partiality toward, again not so much “the world system” that multisited ethnography was originally proposed as a methodological response to,5 as the configurations found within infrastructures, assemblages, complexes, or dispositifs on the part of the ethnographer. These interrelated concepts have been proposed by social scientists in recent decades to try to capture the ways in which particular juridical, medical, social, economic, cultural, and institutional configurations are consolidated over time and in particular places. Michel Foucault spoke of what he called a dispositif or apparatus: “a thoroughly heterogeneous ensemble consisting of discourses, institutions, architectural forms, regulatory decisions, laws, administrative measures, scientific statements, philosophical, moral, and philanthropic propositions. . . . Such are the elements of the apparatus. The apparatus itself is the system of relations that can be established between these elements” (Foucault, 1977). As examples, we have, a decade later in 1989, and invoking American president Dwight Eisenhower’s notion of a “military-industrial complex” from 1961, historian of science David Turnbull arguing that the development of a malaria vaccine through an Australia–Papua New Guinea collaboration in the 1980s could only take place as a “consequence of a complex of technical, social, economic, and political factors” (Turnbull, 1989, p. 283). Within the field of contemporary American health care, anthropologist Sharon Kaufman has likewise mobilized Arnold Relman’s (1980) writings on America’s “new medical-industrial complex” to examine the “increasing encroachment of the private sector into research, technology development, therapeutics, and insurance reimbursement” (Kaufman, 2015, p. 54). Similarly, in her analysis of the development of a repro-tech sector in Israel, Sigrid Vertommen has charted the “emergence of a reproductive-embryonic industrial complex in which the interests of a pronatalist Jewish state and a biomedical establishment—consisting of academic entrepreneurs, venture capitalists, biotech companies, and pharmaceutical giants—have coalesced” (2016, p. 5).
On a global scale, Brian Larkin has recently reignited anthropological interest in infrastructures that he defines as “built networks that facilitate the flow of goods, people, or ideas and allow for their exchange over space. . . . They comprise the architecture for circulation, literally providing the undergirding of modern societies” (Larkin, 2013, p. 328). In a similar vein, Stephen Collier and Aihwa Ong proposed the term global assemblages, which they see as “specific technical infrastructures, administrative apparatuses, or value regimes,” which facilitate the transportation of global phenomena that “have a distinctive capacity for decontextualization and recontextualization, abstractability, and movement, across diverse social and cultural situations and spheres of life” (Collier & Ong, 2007, p. 11). Building on their work, Marcia Inhorn has described a global reproductive assemblage as “involving the global diffusion of IVF and its underlying technoscience; international circuits of travelling people and, increasingly, their body parts (gametes, frozen embryos, and other biological substances); systems of administration involving both medical and tourism industries; increasing regulatory governance, on the part of both nations and professional bodies; and growing ethical concerns about various forms of licit and illicit exchange, including unprecedented evasion across national and international borders” (Inhorn, 2015, p. 22).
Although their terminology differs, each of these scholars